Xilio Therapeutics, Inc. (XLO)
NASDAQ·Healthcare·Biotechnology
$8.66
+5.50%
Mkt Cap $28.36M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$98.00
Range $98.00 – $98.00
Implied Upside
+1032.3%
Consensus $98.00 vs current $8.66
NASDAQ·Healthcare·Biotechnology
$8.66
+5.50%
Mkt Cap $28.36M
No recent rating data.
Price Target (1 analysts)
$98.00
Range $98.00 – $98.00
+1032.3%
Consensus $98.00 vs current $8.66